Cancer Research UK tests first of its kind vaccine to treat lung cancer
A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell…
AstraZeneca won’t submit lung drug for COPD after 2nd study miss
AstraZeneca no longer plans to seek approval of its new respiratory biologic Fasenra in chronic obstructive pulmonary disease (COPD) after the…